Key Words: genomics; machine learning; neoantigens; cancer vaccines; personalized medicine
I received my PhD in Computer Science from NYU, where I worked on machine learning and runtime compilation for parallel hardware. After grad school I switched over to computational cancer immunotherapy research at the Icahn School of Medicine at Mount Sinai, where I helped start and run three personalized cancer vaccine trials. My current line of research focuses on optimizing personalized vaccination through better genomics and machine learning methods, as well as collaborating heavily with experimentalists to optimize vaccine formulation.
- Bias 101
Training Program Affiliations:
- Bioinformatics and Computational Biology
Alex Rubinsteyn in UNC Genetics News
June 28, 2021
Department of Genetics Publications for June 13-26, 2021
Department of Genetics faculty, postdocs, students and collaborators published twenty one papers during June 13-26, 2021.
July 16, 2020
Alexander Rubinsteyn, PhD Receives Career Development Award from AACR
Dr. Alexander Rubinsteyn (Assistant Professor, Genetics) was awarded a Novocure Career Development Award from the American Association for Cancer Research (AACR) for his project titled “Impact of Tumor Treating Fields on Neoantigen Burden and T Cell Function”.
June 29, 2020
Department of Genetics Publications for June 14-27, 2020
Department of Genetics faculty, postdocs, students and collaborators published nine papers during June 14-27, 2020.
April 9, 2020
Department of Genetics Welcomes Drs. Christoph Rau and Alex Rubinsteyn
Christoph Rau, PhD and Alex Rubinsteyn, PhD joined the Department of Genetics/Computational Medicine Program as Assistant Professors on the tenure track, effective March 1, 2020.